D-0157-2027 Class II Ongoing
FDA drug recall D-0157-2027 was initiated by AvKARE on Oct 9, 2026 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is ongoing. Affected quantity: 8866 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 11, 2026
- Initiation Date
- Oct 9, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8866 cartons
Product description
Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 50 Tablets (5 x 10) Unit Dose AVPAK, Manufactured for: AvKARE, Pulaski, TN 38748, NDC 50268-330-15
Reason for recall
Failed Impurities/Degradation Specifications
Distribution pattern
U.S. Nationwide
Code information
Lot # 48353; Exp. 10/31/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0157-2027
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for AvKARE? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.